Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID 19: a clue from innate immunity
Domenico Birra, Maurizio Benucci, Luigi Landolfi, et al.
Immunologic Research (2020) Vol. 68, Iss. 3, pp. 161-168
Open Access | Times Cited: 147

Showing 26-50 of 147 citing articles:

Immune response to SARS-CoV-2 variants: A focus on severity, susceptibility, and preexisting immunity
Eman Alefishat, Herbert F. Jelinek, Mira Mousa, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 2, pp. 277-288
Open Access | Times Cited: 30
Toll-Like Receptor Signaling in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Innate Immune Responses and the Potential Application Value of Toll-Like Receptor Immunomodulators in Patients With Coronavirus Disease 2019
Jiayu Dai, Yibo Wang, Hongrui Wang, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 29
The Role of Inflammatory Cytokines (Interleukin-1 and Interleukin-6) as a Potential Biomarker in the Different Stages of COVID-19 (Mild, Severe, and Critical)
Mina Ghofrani Nezhad, Giti Jami, Omid Kooshkaki, et al.
Journal of Interferon & Cytokine Research (2023) Vol. 43, Iss. 4, pp. 147-163
Closed Access | Times Cited: 17
TNF/IFN-γ Co-Signaling Induces Differential Cellular Activation in COVID-19 Patients: Implications for Patient Outcomes
Lucero A. Ramón‐Luing, Laura E. Martínez-Gómez, Carlos Martínez-Armenta, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1139-1139
Open Access
Morphopathology of the lesions induced by SARS-CoV-2 infection in the lungs
Florin Ionuţ Buibaş, Roberta Andreea Cercel, Mircea-Sebastian Șerbănescu, et al.
Romanian Journal of Morphology and Embryology (2025) Vol. 65, Iss. 4, pp. 637-645
Open Access
Dynamic data-driven meta-analysis for prioritisation of host genes implicated in COVID-19
Nick Parkinson, Natasha Rodgers, Max Head Fourman, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 40
Interleukin-1in COVID-19 Infection: Immunopathogenesis and Possible Therapeutic Perspective
Amirhossein Mardi, Sepideh Meidaninikjeh, Sepideh Nikfarjam, et al.
Viral Immunology (2021) Vol. 34, Iss. 10, pp. 679-688
Closed Access | Times Cited: 38
Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic options
Shetty Ravi Dyavar, Rahul Singh, Rohini Emani, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111794-111794
Open Access | Times Cited: 37
Dipeptidyl peptidase 4 inhibitors: Applications in innate immunity?
Roger Yazbeck, Simone Jaenisch, Catherine A. Abbott
Biochemical Pharmacology (2021) Vol. 188, pp. 114517-114517
Open Access | Times Cited: 36
Immunotherapies and immunomodulatory approaches in clinical trials - a mini review
Mohd. Iqbal Yatoo, Zeenat Hamid, IZHAR AHMAD RATHER, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 7, pp. 1897-1909
Open Access | Times Cited: 32
Andrographolide Induces anti-SARS-CoV-2 Response Through host-directed Mechanism: an in silico Study
B. S. Das, Nabarun Chandra Das, Shasank S. Swain, et al.
Future Virology (2022) Vol. 17, Iss. 9, pp. 651-673
Open Access | Times Cited: 25
Prognostic impact of toll-like receptors gene polymorphism on outcome of COVID-19 pneumonia: A case-control study
Mahmoud M. Alseoudy, Mohamed Elgamal, Dalia A. Abdelghany, et al.
Clinical Immunology (2022) Vol. 235, pp. 108929-108929
Open Access | Times Cited: 24
mRNA expression of toll-like receptors 3, 7, 8, and 9 in the nasopharyngeal epithelial cells of coronavirus disease 2019 patients
Zahra Bagheri‐Hosseinabadi, Ebrahim Rezazadeh Zarandi, Mohammad Mirabzadeh, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 24
Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists
U. Muscha Steckelings, Colin Sumners
Clinical Science (2020) Vol. 134, Iss. 22, pp. 2987-3006
Open Access | Times Cited: 38
Multiepitope Subunit Vaccine Design against COVID-19 Based on the Spike Protein of SARS-CoV-2: An In Silico Analysis
Hamza Arshad Dar, Yasir Waheed, Muzammil Hasan Najmi, et al.
Journal of Immunology Research (2020) Vol. 2020, pp. 1-15
Open Access | Times Cited: 34
Immuno-informatics approach for multi-epitope vaccine designing against SARS-CoV-2
Souvik Banerjee, Kaustav Majumder, Gerardo Jose Gutierrez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 32
New perspectives on natural flavonoids on COVID‐19‐induced lung injuries
Fernanda Paula Roncon Santana, Fernanda Thevenard, Kaio S. Gomes, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 9, pp. 4988-5006
Open Access | Times Cited: 28
Low anti‐SARS‐CoV‐2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID‐19 patients
María Martin‐Vicente, Raquel Almansa, Isidoro Martínez, et al.
Journal of Internal Medicine (2021) Vol. 291, Iss. 2, pp. 232-240
Open Access | Times Cited: 28
SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases
Regina Larionova, K. Byvaltsev, О. А. Кравцова, et al.
Journal of Translational Autoimmunity (2022) Vol. 5, pp. 100154-100154
Open Access | Times Cited: 20
New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic
Jonatan J. Carvajal, Valeria García-Castillo, Shelsy V. Cuellar, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
A case report of monoarthritis in a COVID-19 patient and literature review
Gilberto Cincinelli, Raffaele Di Taranto, Francesco Orsini, et al.
Medicine (2021) Vol. 100, Iss. 23, pp. e26089-e26089
Open Access | Times Cited: 26
Cytokine storm in the pathophysiology of COVID-19: Possible functional disturbances of miRNAs
Mona Aslani, Seyed Shahabeddin Mortazavi‐Jahromi, Abbas Mirshafiey
International Immunopharmacology (2021) Vol. 101, pp. 108172-108172
Open Access | Times Cited: 26
A Novel SARS-CoV-2 Viral Sequence Bioinformatic Pipeline Has Found Genetic Evidence That the Viral 3′ Untranslated Region (UTR) Is Evolving and Generating Increased Viral Diversity
Carlos Farkas, Andy Mella, Maxime Turgeon, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 24
Systematic Review and Meta-Analysis of Tocilizumab Therapy versus Standard of Care in over 15,000 COVID-19 Pneumonia Patients during the First Eight Months of the Pandemic
Naim Mahroum, ‬‬‬‬Abdulla Watad, Charlie Bridgewood, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 17, pp. 9149-9149
Open Access | Times Cited: 23
Concurrent myopathy and inflammatory cardiac disease in COVID-19 patients: a case series and literature review
Ophir Freund, Tali Eviatar, Gil Bornstein
Rheumatology International (2022) Vol. 42, Iss. 5, pp. 905-912
Open Access | Times Cited: 17

Scroll to top